Interestingly, the TNFRSF1A locus has been validated as a MS susceptibility gene as the disease-associated genetic variant leads to the expression of a soluble form of TNFR1 that sequesters TNF and thereby abrogates signaling through TNFR242. This evidence concerns the gene TNFRSF1A and myeloid sarcoma.